UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046799
Receipt number R000053395
Scientific Title Effect of Exercise for the Adults with Spinal Cord Injury Using Scientific Exercise Guideline -Preliminary Randomized Controlled Trial-
Date of disclosure of the study information 2022/03/01
Last modified on 2022/02/01 20:11:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Exercise for the Adults with Spinal Cord Injury Using Scientific Exercise Guideline

Acronym

Effect of Exercise for the Adults with Spinal Cord Injury

Scientific Title

Effect of Exercise for the Adults with Spinal Cord Injury Using Scientific Exercise Guideline -Preliminary Randomized Controlled Trial-

Scientific Title:Acronym

Effect of Exercise for the Adults with Spinal Cord Injury Using Scientific Exercise Guideline

Region

Japan


Condition

Condition

Spinal Cord Injury

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study is a pilot study to evaluate the preliminary effectiveness of exercise using the Japanese version of "Scientific Exercise Guideline for Adults with SCI" to explore the effectiveness of exercise for adult spinal cord injury in Asian countries.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

Maximum oxygen uptake, upper limb muscle strength (grip strength)

Key secondary outcomes

Body composition (muscle / fat mass), blood biochemical test results (blood glucose / lipid / liver function / renal function), amount of activity


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Rehabilitation

Interventions/Control_2

6months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Adults with chronic spinal cord injury who are living at home, have no exercise habits, and are outpatients.

Key exclusion criteria

Adults with cervical spinal cord injury, spinal cord injury less than 12 months after onset, elderly people over 65 years old, people with comorbidities such as cognitive dysfunction / mental disorder, people with chronic diseases that are not appropriate for exercise, Patients with inadequate measurement of maximum oxygen uptake.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yukio
Middle name
Last name Mikami

Organization

Wakayama Medical University

Division name

Rehabilitation Medicine

Zip code

6418509

Address

Kimiidera 811-1, Wakayama city

TEL

+81-73-441-0664

Email

ymikami@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Yukio
Middle name
Last name Mikami

Organization

Wakayama Medical University

Division name

Rehabilitation Medicine

Zip code

6418509

Address

Kimiidera 811-1, Wakayama city

TEL

+81-73-441-0664

Homepage URL


Email

ymikami@wakayama-med.ac.jp


Sponsor or person

Institute

Ministry of education

Institute

Department

Personal name



Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee of Wakayama Medical University

Address

Kimiidera 811-1, Wakayama city

Tel

+81-73-447-2300

Email

wa-rinri@wakayama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 01 Month 27 Day

Date of IRB


Anticipated trial start date

2022 Year 03 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 02 Month 01 Day

Last modified on

2022 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053395